M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma

被引:29
作者
de Vries, W. M. [1 ,2 ]
Briaire-de Bruijn, I. H. [1 ]
van Benthem, P. P. G. [2 ]
van der Mey, A. G. L. [2 ]
Hogendoorn, P. C. W. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Pathol, POB 9600, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Dept Otolaryngol, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands
关键词
IL-34; Macrophage colony stimulating factor; Vestibular schwannoma; TUMOR-ASSOCIATED MACROPHAGES; BREAST-CANCER; RECEPTOR; GENE; NEUROFIBROMATOSIS-2; INTERLEUKIN-34; CHEMOTHERAPY; PROGRESSION; ACTIVATION; CYTOKINE;
D O I
10.1007/s00428-018-2503-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Macrophage colony stimulating factor and IL-34 are associated with clinical vestibular schwannoma progression. Investigating the biology behind vestibular schwannoma progression helps understanding tumor growth. Inflammation is important in the microenvironment of neoplasms. Macrophages are major players in the intratumoral infiltrate. These tumor-associated macrophages are known to stimulate angiogenesis and cell growth. M-CSF and IL-34 are cytokines that can regulate tumor-infiltrating macrophages. They are expressed by tumors and form potential targets for therapy. The goal of this study was to investigate these cytokines in vestibular schwannomas and to see if their expression is related to angiogenesis, macrophage numbers, cystic degeneration, and volumetric tumor progression. Immunohistochemical expression of M-CSF and IL-34 was analyzed in ten fast-growing vestibular schwannomas and in ten slow-growing vestibular schwannomas. Expression M-CSF and IL-34 were compared between fast- versus slow-growing and cystic versus non-cystic tumors. Data on macrophage numbers and microvessel density, known from earlier research, was also included. All tumors expressed M-CSF and its expression was higher in fast-growing tumors (p=0.003) and in cystic tumors (p=0.035). CD163 expression was higher in tumors with strong M-CSF expression (p=0.003). All tumors expressed IL-34 as well, but no significant differences were found in relation to clinicopathological characteristics. This study demonstrated the expression of M-CSF and IL-34 in vestibular schwannomas. The results suggest that M-CSF is related to macrophage activity and tumor progression, making it a potential target for therapy. If a similar assumption can be made for IL-34 remains unclear.
引用
收藏
页码:375 / 381
页数:7
相关论文
共 32 条
  • [1] Jekyll and Hyde: the role of the microenvironment on the progression of cancer
    Allen, Michael
    Jones, J. Louise
    [J]. JOURNAL OF PATHOLOGY, 2011, 223 (02) : 162 - 176
  • [2] Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
    Baghdadi, Muhammad
    Wada, Haruka
    Nakanishi, Sayaka
    Abe, Hirotake
    Han, Nanumi
    Putra, Wira Eka
    Endo, Daisuke
    Watari, Hidemichi
    Sakuragi, Noriaki
    Hida, Yasuhiro
    Kaga, Kichizo
    Miyagi, Yohei
    Yokose, Tomoyuki
    Takano, Atsushi
    Daigo, Yataro
    Seino, Ken-ichiro
    [J]. CANCER RESEARCH, 2016, 76 (20) : 6030 - 6042
  • [3] Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma
    Baranski, Zuzanna
    Booij, Tijmen H.
    Cleton-Jansen, Anne-Marie
    Price, Leo S.
    van de Water, Bob
    Bovee, Judith V. M. G.
    Hogendoorn, Pancras C. W.
    Danen, Erik H. J.
    [J]. JOURNAL OF PATHOLOGY, 2015, 236 (03) : 348 - 359
  • [4] Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
    Cannarile, Michael A.
    Weisser, Martin
    Jacob, Wolfgang
    Jegg, Anna-Maria
    Ries, Carola H.
    Ruettinger, Dominik
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [5] Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
    Dammeijer, Floris
    Lievense, Lysanne A.
    Kaijen-Lambers, Margaretha E.
    van Nimwegen, Menno
    Bezemer, Koen
    Hegmans, Joost P.
    van Hall, Thorbald
    Hendriks, Rudi W.
    Aerts, Joachim G.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2017, 5 (07) : 535 - 546
  • [6] Tumor-Associated Macrophages Are Related to Volumetric Growth of Vestibular Schwannomas
    de Vries, Maurits
    Briaire-de Bruijn, Inge
    Malessy, Martijn J. A.
    de Bruine, Sica F. T.
    van der Mey, Andel G. L.
    Hogendoorn, Pancras C. W.
    [J]. OTOLOGY & NEUROTOLOGY, 2013, 34 (02) : 347 - 352
  • [7] Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas
    de Vries, Maurits
    Hogendoorn, Pancras C. W.
    Briaire-de Bruyn, Inge
    Malessy, Martijn J. A.
    van der Mey, Andel G. L.
    [J]. VIRCHOWS ARCHIV, 2012, 460 (06) : 629 - 636
  • [8] CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing
    Ding, Jingxian
    Guo, Chungen
    Hu, Pinghua
    Chen, Jun
    Liu, Qiuming
    Wu, Xiaobo
    Cao, Yali
    Wu, Jiong
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (05) : 2064 - 2074
  • [9] Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: Higher incidence than previously thought
    Evans, DGR
    Moran, T
    King, A
    Saeed, S
    Gurusinghe, J
    Ramsden, R
    [J]. OTOLOGY & NEUROTOLOGY, 2005, 26 (01) : 93 - 97
  • [10] Howitz MF, 2000, AM J OTOL, V21, P690